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PREVALENCE OF CELIAC DISEASE
AMONG FIRST DEGREE RELATIVES  
OF BRAZILIAN CELIAC PATIENTS
Patrícia Lopes de ALMEIDA1, Lenora GANDOLFI1, 2, Inês Cristina MODELLI1,  
Rita de Cássia MARTINS2, Rodrigo Coutinho de ALMEIDA2 and Riccardo PRATESI1, 2
ABSTRACT – Background - Several studies have shown that celiac disease, an autoimmune disorder that occurs in genetically susceptible 
individuals, is highly prevalent among relatives of celiac patients. Aim - To determine the prevalence of celiac disease in a group of first 
degree relatives of Brazilian celiac patients. Methods - First degree relatives of celiac patients attending the Brasilia University Hospital 
Pediatric Gastroenterology Outpatient Clinic or the Celiac Disease Investigation Center, Brasília, DF, Brazil, between March 2001 
and November 2004 were invited to undergo serological screening for celiac disease applying the IgA anti-endomysium antibody test 
(IgA-EMA). All positive IgA-EMA sera underwent a second screening using the IgA anti-tissue transglutaminase antibodies test. Duodenal 
or small intestinal biopsies were performed in all subjects positive to serological testing. Biopsy samples were classified as type (O) normal, 
(I) infiltrative, (II) infiltrative hyperplastic, (III) flat destructive, and (IV) atrophic hypoplastic. The final diagnosis was ascertained in subjects 
showing positive serological tests and a grade I to III small intestinal lesion. Results - Nine new cases of celiac disease were found among 
the 188 first degree relatives tested (4.8%). Conclusion - The present study confirms the high prevalence of celiac disease among first degree 
celiac patients’ relatives and reinforces the need of extensive diagnostic screening in this specific group.
HEADINGS – Celiac disease, genetics. Brazil.
INTRODUCTION
Celiac disease (CD) is an immune-mediated disorder 
that occurs in genetically susceptible individuals in which 
the ingestion of dietary gluten causes intestinal mucosa 
inflammation, crypt hyperplasia, and villous atrophy. 
The disease is associated with human leucocyte antigen 
(HLA), its primary susceptibility being linked to the 
presence of HLA-DQ2 and DQ8 haplotypes. However 
HLA genes contribute with no more than 40% of the 
risk, undetermined non-HLA genes probably being the 
stronger determinant of CD susceptibility(18).
In the last 25 years the emergence of progressively 
more reliable serological markers, such as anti-gliadin, 
anti-endomysium(30), and anti-transglutaminase antibodies(29) 
allowed the precocious diagnosis of atypical or even 
silent form of the disease and greatly contributed to the 
widespread acknowledging that the prevalence of CD 
was higher than previously thought. Presently CD may 
be considered a global public health problem and one of 
the most common chronic auto-immune conditions since 
its estimated figures in Western countries varies between 
1% and 2.5%(9, 19). 
In South America CD was considered a rare disease 
and its prevalence in the general population was mostly 
unknown. The increased interest in this polymorphic 
disease during the last decade resulted in several 
screening studies. In Brazil GANDOLFI et al.(10) reported 
a prevalence of 1:681 (0.14%) in presumably healthy 
blood donors. In the same geographical region PRATESI 
et al.(27) studying a group of 4,405 adults and children 
without gastroenterological complaints attending the 
laboratory of clinical analysis of a large hospital for 
routine blood testing encountered a prevalence of 1:293 
(0.34%) of biopsy proven CD patients. Other recent 
screening studies in Brazil also disclosed expressive 
results. MELO et al.(22) found a prevalence of 1:273 
(0.36%) among 3,000 blood donors in Ribeirão Preto city, 
in the State of São Paulo. PEREIRA et al.(26) screening a 
population of predominantly European ancestry detected 
a prevalence of 1:415 (0.24%). OLIVEIRA et al.(25) in the 
city of São Paulo, also studying a group of 3,000 potential 
blood donors found a prevalence of 1:214 (0.47%). 
Expressive results were also obtained by GOMEZ et 
al.(11) in Argentina. Studying 2,000 adults attending an 
obligatory prenuptial examination, the authors found a 
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prevalence of 1:167 (0.59%). Therefore it becomes evident that 
prevalence of CD in South America is higher than previously 
thought and is probably underdiagnosed.
Untreated CD predisposes individuals to several complications, 
some related to malabsorption, such as osteopenia or iron-
deficient anemia (arising from one or more of iron, folate 
and vitamin B-12 deficiency), and some associated with the 
underlying autoimmune process, such as type 1 diabetes and 
thyroiditis. Other reported complications are delayed puberty, 
early menopause, infertility, miscarriage, depression, and 
neurological disorders (epilepsy with cerebral calcifications, 
ataxia, and peripheral neuropathy). However, the most 
feared complication is the development of malignancy of the 
gastrointestinal tract, mainly non-Hodgkin lymphoma that is 
the most probable reason for the increased mortality in non 
treated celiac patients(5, 21).
CD is a familial disorder and families with more than one 
affected member are common. A higher prevalence of CD among 
relatives of celiac patients has been demonstrated by several 
studies(1, 2, 3, 6, 8, 9, 14, 15, 23, 31) fully justifying an active search for 
undiagnosed CD among this at-risk group.
Two studies, assessing the prevalence of CD among relatives 
of celiac patients have been previously performed in Brazil. 
The first, by NUNES et al.(24) disclosed a prevalence of 0.8% 
among a group of 121 relatives. The main focus of the second 
study, by KOTZE et al.(16) was to determine specificity and 
sensitivity of the antiendomysium antibody test performed 
on cryostatic sections of human umbilical cord, in a group 
of confirmed celiac patients and their first-degree relatives. 
Among the 18 serological positive first-degree relatives seven 
agreed to underwent intestinal biopsy. One of these patients 
disclosed the characteristic mucosal abnormalities of CD 
and the remaining six showed only an increased number of 
intra-epithelial lymphocytes. 
The objective of the present study is consequently to determine 
the prevalence of CD in a group of first degree relatives of 
biopsy-proven CD patients. 
METHODS
The present study was performed according to the 
Declaration of Helsinki and approved by the School of Health 
Sciences Ethics Committee. All subjects were informed about 
the objectives of the study and the eventual necessity of 
small intestinal biopsy. Informed consent was obtained from 
adults and from the parents for their children. First degree 
relatives of CD patients attending the Brasilia University 
Hospital Pediatric Gastroenterology out-patient clinic or the 
Celiac Disease Investigation Center, Brasília, DF, Brazil, 
between March 2001 and November 2004 were invited to 
undergo serological screen for CD. The Celiac Disease 
Center is a weekly walking-in clinic open for diagnosis 
and follow-up of CD patients, attending both children and 
adults. The diagnosis of CD patients had been based on the 
modified European Society of Paediatric Gastroenterology 
and Nutrition (ESPGAN) criteria(32). All family members 
were on a gluten-containing diet when serological tests were 
performed. Each blood samples obtained was centrifuged and 
the resulting serum was stored at -20° until testing. The IgA 
anti-endomysium antibody indirect immunofluorescent test 
(IgA-EMA)(4) was used as first-level screening. Briefly, fixed 
cryostat sections of the distal portions of primate (Cebus apella) 
esophagus were used as antigen substrate. Fluorescein-labeled 
goat antibody to human IgA was used as a second antibody. 
All sera were screened at a dilution of 1/5. The presence of 
characteristic brilliant green network pattern, under fluorescent 
light microscope, was considered positive. All positive IgA-
EMA sera underwent a second screening, being tested for 
the presence of IgA anti-tissue transglutaminase antibodies 
(IgA-tTG) using an ELISA method (Quanta Lite Human tTG 
IgA – INOVA Diagnostic Inc, San Diego, CA, USA). Optical 
density was reported in arbitrary unit as a percentage of the 
optical density of a pool of positive samples, being 20 units 
the upper normal limit range (cut-off value), as determined 
by the manufacturer. Duodenal or small intestinal biopsy was 
recommended to subjects showing positive results to serological 
testing. Children underwent small intestinal biopsy with a 
Watson pediatric capsule, samples being taken at the ligament 
of Treitz. In adults, biopsy samples were obtained through an 
endoscopy procedure, using an Olympus gastroscope (Tokyo, 
Japan) with four to five fragments being taken from the second 
portion of the duodenum. All biopsy specimens were blindly 
evaluated by a pathologist and a gastroenterologist and classified 
according to Marsh classification(20) as type 0, normal. Type 
I, infiltrative pattern, with normal mucosal architecture with 
increased infiltration of intraepithelial lymphocytes (IELs). 
In the present study, a count of 25 IELs/100 epithelial cells 
was taken as the upper limit of the normal range(13, 17). Type 
II infiltrative hyperplastic, similar to the type I, showing in 
addition enlargement of the crypts. Type III, flat destructive, 
characterized by villous atrophy crypt hyperplasia and increased 
number of IELs. Type IV, atrophic hypoplastic, showing total 
villous atrophy and hypoplastic cripts. The diagnosis of CD 
was finally ascertained in subjects showing positive serological 
tests and a grade I to III small intestinal lesion. 
RESULTS
One hundred-eighty-eight first degree relatives (113/60% 
females and 75/40% males, age range 1 to 75 years, mean age 
29.9 years, SD 16.8) out of 307 relatives of 72 CD patients 
agreed with the screening procedure and, after obtaining informed 
consent, underwent serological testing. Family members tested 
included 102 parents (42 fathers and 60 mothers, aged 25 to 
75 years, median age 36 years), 76 siblings (31 brothers and 
45 sisters, aged 1 to 75 years, median age 11.5 years), and 
10 offspring (2 males and 8 females, aged 1-45 years, median 
age 9.5 years). Positive IgA-EMA was found in 9 first 
degree relatives (5 sisters, 1 brother and 3 mothers). All nine 
IgA-EMA positive subjects also showed high levels of IgA-tTG 
(Table 1) Histological changes characteristic of CD were 
found in all nine subjects identified by serological testing. 
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The prevalence of CD among the first degree relatives was 
9/188 (4.8%). No positive case was found among the 10 celiac 
patients’ offspring. The main data concerning the nine biopsy 
proven CD patient are shown in Table 1. 
DISCUSSION
It has long been known that symptomatic CD is more frequent 
among relatives of celiac patients. In view of the probable 
complications of an undiagnosed and untreated CD, it is important 
to identify family members, mainly those with a silent form of 
the disease to offer them the benefit of gluten free diet. 
In the present study the prevalence of CD among the first 
degree relatives was 4.8 %. Our results are similar to the 
result found by FASANO et al.(9) that reported a prevalence 
of 4.5% new cases among 205 first degree relatives of celiac 
patients. Previous screening studies based on serological tests, 
among first degree relatives of celiac patients, have shown 
appreciable variation in the prevalence of CD. VITORIA et 
al.(31) in one of the earliest European studies on the subject 
observed a prevalence of 2.8%, substantially lower than that 
observed in subsequent studies, in which the prevalence 
varied between 4.5%(9) to 9.5%(2). These differences could 
be partially explained by methodological differences in the 
various studies and by the variability of the genetic background 
of the distinct population evaluated. 
The higher prevalence found among the 76 siblings (7.9%) than 
among the 102 parents (2.9%), although not statistically significant, 
follows a tendency observed in other studies in which an increased 
number of affected siblings was also observed(1, 2, 3, 8, 15).
The prevalence of CD among first-degree relatives dramatically 
increases when considered only families with two or more cases 
of CD. In two studies focusing these families the prevalence 
reported was respectively 9.4%(23) and 17.2%(3). In the present 
work two families showed more than two affected members. Of 
interest was the diagnosis of CD in a 3 year-old girl that led to 
the discovery of CD in other family members, respectively her 
mother and two maternal uncles. These multiple CD cases in the 
same family are not rare and the risk of CD, although decreased, 
is still significant in second degree relatives(3). 
It is important to stress that a negative result do not 
exclude the possible future appearance of CD in a relative 
of a CD patient. In an interesting 20 year follow-up study, 
HOGBERG et al.(14) found two new cases of CD among 
120 relatives previously screened and considered negative. 
Among the siblings tested in the present study a female 
patient that, at the time of her sister CD diagnosis had 
tested negative become symptomatic and was diagnosed as 
celiac 5 years later, disclosing positive serological tests and 
typical abnormalities on duodenal biopsy. The only way to 
definitely exclude the risk of future CD would be the HLA 
genotyping confirming the absence of the predisposing 
alleles, DQA1*0501 and DQB1*0201 (encoding the DQ2 
heterodimer), present in approximately 95% of CD patients, 
and DRB1*04 (associated with the DQ8 heterodimer) found 
in the remaining 5%. Genotyping, although dependent on 
a more difficult and expensive technique, would allow the 
exclusion of a considerable proportion of first degree relatives 
of CD probands from further screening for CD(8).
Among the nine parents diagnosed as celiac only one 
patient disclosed symptoms that could be considered as part 
of the classic manifestations of CD. The remaining patients 
showed atypical form of the disease and one had no specific 
complaints. Histopathologic examination of eight biopsy 
samples disclosed typical abnormalities classified as Marsh 
III. Only a biopsy sample from an 8 year-old girl with both 
positive IgA-tTG and IgA-EMA tests showed increased number 
of IELs as single abnormality (infiltrative type of lesion or 
Marsh I). Increased number of intraepithelial lymphocytes has 
been considered typical of CD(12, 20), although no necessarily 
specific since it can be found in other disorders as, for example, 
small intestinal bacterial overgrowth(28). In this particular 
child both serological tests were undoubtedly positive and, 
in addition, her follow-up revealed a progressive quiescence 
of her symptoms and normalization of both serological tests 
after being started on gluten free diet.
In conclusion, the present study, utilizing sensitive and 
specific serological tests, could identify 9 undiagnosed cases 
of CD among 188 first degree relatives of 72 celiac patients, 
confirming the high prevalence of the disease in this specific 
group. This study corroborates other studies on the same subject(1, 
2, 3, 7, 14, 31) and reinforces the fact that relatives of CD patients are 
a population at high risk of developing gluten intolerance. An 
extensive screening policy is consequently mandatory in these 
subjects, especially in members of families in which more than 
a member is affected. 





Symptoms IgA-EMA IgA-tTG Biopsy
1 Sister 8 Recurrent abdominal cramps, apathy, decreased appetite, mouth ulcers. + 82,8 U Marsh I
2 Sister 9 Constipation, abdominal distention, bloating. + 116,4 U Marsh III
3 Sister 23 No clinical symptoms. + 213,2 U Marsh III
4 Sister 43 Irritability, apathy, muscle and joint pain, anemia, osteoporosis. + 135,5 U Marsh III
5 Sister 75 Abdominal distension, bloating. + - Marsh III
6 Brother 2 Irritability, abdominal distension. + 246,5 U Marsh III
7 Mother 25 Frequent diarrhea, abdominal distension, bloating, mouth ulcers. + 220,2 U Marsh III
8 Mother 30 Irritability, abdominal distension, bloating, recurrent abdominal cramps, apathy, painful joints. + 269,5 U Marsh III
9 Mother 39 Painful joints, osteoporosis + 175 U Marsh III
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Almeida PL, Gandolfi L, Modelli IC, Martins RC, Almeida RC, Pratesi R.  Prevalência da doença celíaca em parentes de primeiro grau de pacientes celíacos 
brasileiros.  Arq Gastroenterol. 2008;45(1):69-72.
RESUMO – Racional - Vários estudos têm evidenciado que a doença celíaca, afecção auto-imune que ocorre em indivíduos geneticamente susceptíveis, apresenta 
prevalência aumentada entre parentes de pacientes celíacos. Objetivo - Determinar a prevalência da doença celíaca em grupo de parentes de primeiro grau 
de pacientes celíacos brasileiros. Métodos - Parentes de primeiro grau de pacientes celíacos atendidos no Ambulatório de Gastroenterologia Pediátrica do 
Hospital Universitário de Brasília e no Centro de Pesquisas da Doença Celíaca da Faculdade de Medicina da Universidade de Brasília entre março de 2001 
e novembro de 2004 foram testados para detectar a possível presença de anticorpos anti-endomísio (IgA-EMA). Todos os soros IgA-EMA positivos foram 
submetidos a um segundo teste confirmando a sua positividade sorológica pela presença de anticorpos anti-transglutaminase (IgA-tTG). Biopsias jejunais 
ou duodenais foram efetuadas em todos os indivíduos com sorologia positiva. As amostras de mucosa foram histologicamente classificadas de acordo com a 
classificação de Marsh em tipo (0) normal, (I) infiltrativa, (II) hiperplásica infiltrativa, (III) destrutiva plana e (IV) hipoplásica atrófica. O diagnóstico conclusivo 
foi firmado com base na positividade dos testes sorológicos e na presença de lesões intestinais de grau de I a III. Resultados - Nove novos casos de doença 
celíaca foram detectados dentre os 188 parentes de primeiro grau de pacientes celíacos (4.8%). Conclusão - Confirma-se a alta prevalência de doença celíaca 
entre parentes de primeiro grau de celíacos e reforça-se a necessidade de investigação diagnóstica rotineira deste grupo específico de indivíduos.
DESCRITORES – Doença celíaca, genética. Brasil.
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